Search

Search Constraints

You searched for: Author/Creator Heitz, Florian

Search Results

1. 2022-RA-1008-ESGO The impact of cytoreductive surgery in FIGO IV and recurrent endometrial cancer. (20th October 2022)

2. 2022-RA-1192-ESGO NOGGO ov44 – PERCEPTION What is the role of immunotherapy in low grade ovarian cancer? A NOGGO phase II trial of pembrolizumab in combination with chemotherapy in recurrent low-grade serous ovarian cancer. (20th October 2022)

3. 2022-RA-1402-ESGO Implementing HRD testing in routine clinical practice among patients with primary high-grade advanced ovarian cancer. (20th October 2022)

4. 2022-RA-1492-ESGO Homologous recombination deficiency (HRD): a new ovarian cancer biomarker – validation of decentralized genomic profiling, with a focus on genomic large rearrangements (LRs). (20th October 2022)

5. 2022-RA-1515-ESGO Impact of surgical staging on survival of low grade endometrioid ovarian cancer apparently confined to the ovary. (20th October 2022)

6. 2022-RA-1533-ESGO Role of fertility sparing surgery in patients with borderline ovarian tumors. (20th October 2022)

7. 2022-RA-285-ESGO Real world data of treatment and outcome of patients with early ovarian cancer (FIGO I) in Germany (QS Ovar of the AGO Study Group). (20th October 2022)

8. 2022-RA-420-ESGO Treatment and outcome of patients with high-grade advanced ovarian cancer (AOC) – real world data of the german quality assurance project (QS Ovar of the AGO Study Group). (20th October 2022)

9. 2022-RA-755-ESGO Comparison of PD-L1 status between primary and paired recurrent/metastatic cervical cancer. (20th October 2022)

10. 2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM. (20th October 2022)